These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 37455938)

  • 61. Clinical significance of homocysteine (hcy) on dementia in Parkinson's disease (PD).
    Song IU; Kim JS; Park IS; Kim YD; Cho HJ; Chung SW; Lee KS
    Arch Gerontol Geriatr; 2013; 57(3):288-91. PubMed ID: 23706974
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.
    Svenningsson P; Westman E; Ballard C; Aarsland D
    Lancet Neurol; 2012 Aug; 11(8):697-707. PubMed ID: 22814541
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neurocognitive speed and inconsistency in Parkinson's disease with and without incipient dementia: an 18-month prospective cohort study.
    de Frias CM; Dixon RA; Camicioli R
    J Int Neuropsychol Soc; 2012 Jul; 18(4):764-72. PubMed ID: 22621940
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
    Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Receiver operating characteristic curve in diagnostic test assessment.
    Mandrekar JN
    J Thorac Oncol; 2010 Sep; 5(9):1315-6. PubMed ID: 20736804
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests.
    Strobl C; Malley J; Tutz G
    Psychol Methods; 2009 Dec; 14(4):323-48. PubMed ID: 19968396
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Changing perspectives regarding late-life dementia.
    Fotuhi M; Hachinski V; Whitehouse PJ
    Nat Rev Neurol; 2009 Dec; 5(12):649-58. PubMed ID: 19918254
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The epidemiology of dementia associated with Parkinson disease.
    Aarsland D; Kurz MW
    J Neurol Sci; 2010 Feb; 289(1-2):18-22. PubMed ID: 19733364
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.
    Camicioli RM; Bouchard TP; Somerville MJ
    Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neurocognitive markers of cognitive impairment: exploring the roles of speed and inconsistency.
    Dixon RA; Garrett DD; Lentz TL; MacDonald SW; Strauss E; Hultsch DF
    Neuropsychology; 2007 May; 21(3):381-99. PubMed ID: 17484601
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease.
    Weintraub D; Oehlberg KA; Katz IR; Stern MB
    Am J Geriatr Psychiatry; 2006 Feb; 14(2):169-75. PubMed ID: 16473982
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.
    Fischl B; Salat DH; Busa E; Albert M; Dieterich M; Haselgrove C; van der Kouwe A; Killiany R; Kennedy D; Klaveness S; Montillo A; Makris N; Rosen B; Dale AM
    Neuron; 2002 Jan; 33(3):341-55. PubMed ID: 11832223
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease.
    Brown GG; Rahill AA; Gorell JM; McDonald C; Brown SJ; Sillanpaa M; Shults C
    J Geriatr Psychiatry Neurol; 1999; 12(4):180-8. PubMed ID: 10616865
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A guide to the standardized Mini-Mental State Examination.
    Molloy DW; Standish TI
    Int Psychogeriatr; 1997; 9 Suppl 1():87-94; discussion 143-50. PubMed ID: 9447431
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The California Verbal Learning Test: psychometric characteristics and clinical application.
    Elwood RW
    Neuropsychol Rev; 1995 Sep; 5(3):173-201. PubMed ID: 8653108
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT).
    Doty RL; Marcus A; Lee WW
    Laryngoscope; 1996 Mar; 106(3 Pt 1):353-6. PubMed ID: 8614203
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Clinical Dementia Rating (CDR): current version and scoring rules.
    Morris JC
    Neurology; 1993 Nov; 43(11):2412-4. PubMed ID: 8232972
    [No Abstract]   [Full Text] [Related]  

  • 78. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.
    Cummings JL; Mega M; Gray K; Rosenberg-Thompson S; Carusi DA; Gornbein J
    Neurology; 1994 Dec; 44(12):2308-14. PubMed ID: 7991117
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of two screening tests in Alzheimer's disease. The correlation and reliability of the Mini-Mental State Examination and the modified Blessed test.
    Fillenbaum GG; Heyman A; Wilkinson WE; Haynes CS
    Arch Neurol; 1987 Sep; 44(9):924-7. PubMed ID: 3619711
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
    Gibb WR; Lees AJ
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):745-52. PubMed ID: 2841426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.